Healthfore Technologies
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -22.5% over past five years.
- Company has high debtors of 236 days.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 4 | 3 | 3 | 3 | 10 | 8 | 3 | 5 | 2 | 4 | 4 | 2 |
| Expenses | 4 | 5 | 5 | 5 | 4 | 8 | 7 | 6 | 5 | 3 | 3 | 4 | 4 |
| Operating Profit | 0 | 0 | -2 | -2 | -1 | 2 | 1 | -3 | 0 | -2 | 1 | 0 | -2 |
| OPM % | 3.3% | -8% | -74% | -85% | -50% | 19% | 12% | -125% | 9% | -119% | 26% | -3.1% | -76% |
| Other Income | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 64 | 0 | 0 |
| Interest | 16 | 17 | 17 | 17 | 17 | 18 | 20 | 20 | 20 | 21 | 19 | 8 | 8 |
| Depreciation | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| PBT | -16 | -17 | -18 | -20 | -19 | -17 | -20 | -25 | -21 | -24 | 45 | -9 | -11 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -16 | -17 | -18 | -20 | -19 | -17 | -20 | -25 | -21 | -24 | 45 | -9 | -11 |
| EPS (₹) | -19.42 | -20.36 | -22.49 | -24.02 | -23.31 | -20.71 | -24.22 | -30.31 | -25.67 | -29.28 | 55.45 | -11.05 | -13.92 |
Profit & Loss
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 125 | 93.52 | 61.92 | 21.22 | 27.25 | 19.83 | 18.36 | 17.31 | 11.31 |
| Expenses | 156 | 135 | 85.29 | 37.24 | 35.56 | 20.86 | 22.06 | 20.88 | 13.68 |
| Operating Profit | -30.94 | -41.39 | -23.37 | -16.02 | -8.31 | -1.03 | -3.7 | -3.57 | -2.37 |
| OPM % | -24.72% | -44.26% | -37.74% | -75.49% | -30.5% | -5.19% | -20.15% | -20.62% | -20.95% |
| Other Income | 1.52 | 1.03 | 14.69 | 9.91 | 2.31 | 10.6 | 4.5 | 1.32 | 64.97 |
| Interest | 6.79 | 17.51 | 47.3 | 49.13 | 46.93 | 61.38 | 68.79 | 80.74 | 55.74 |
| Depreciation | 4.22 | 12.3 | 16.95 | 12.65 | 12.64 | 7.79 | 5.61 | 5.98 | 5.89 |
| PBT | -40.43 | -70.17 | -72.93 | -67.89 | -65.57 | -59.6 | -73.6 | -88.97 | 0.97 |
| Tax % | 0.35% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -40.57 | -70.17 | -72.93 | -67.89 | -65.57 | -59.6 | -73.6 | -88.97 | 0.98 |
| EPS (₹) | — | -86.32 | -89.71 | -83.51 | -80.66 | -73.31 | -90.53 | -109 | 1.2 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 |
| Reserves | -51.26 | -121 | -194 | -262 | -328 | -388 | -461 | -550 |
| Borrowings | 35.01 | 209 | 392 | 316 | 393 | 508 | 530 | 589 |
| Other Liabilities | 105 | 30.16 | 23.22 | 18.25 | 12.07 | 18.69 | 21.73 | 54.69 |
| Total Liabilities | 97.07 | 126 | 229 | 80.3 | 85.61 | 147 | 98.17 | 102 |
| Fixed Assets | 38.04 | 47.03 | 30.39 | 16.33 | 13.35 | 32.35 | 38.09 | 32.49 |
| CWIP | 0.16 | 0 | 5.19 | 14.54 | 15.08 | 0.01 | 0 | 11.5 |
| Investments | 3.09 | 3.09 | 3.09 | 3.09 | 4.41 | 0 | 0 | 0 |
| Other Assets | 55.78 | 75.41 | 191 | 46.34 | 52.77 | 114 | 60.08 | 57.52 |
| Total Assets | 97.07 | 126 | 229 | 80.3 | 85.61 | 147 | 98.17 | 102 |
Cash Flow
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|
| Operating | 54.64 | -73.16 | -30.1 | -15.25 | 9.37 | -48.94 | 59.77 | 64.91 |
| Investing | -29.51 | -21.85 | -113 | 137 | -16.37 | -9.33 | -7.96 | -11.43 |
| Financing | -25.4 | 101 | 140 | -124 | 8.93 | 57.09 | -52.01 | -55.17 |
| Net Cash Flow | -0.27 | 5.86 | -3.38 | -1.74 | 1.93 | -1.18 | -0.2 | -1.69 |
| Free Cash Flow | 28.22 | -94.41 | -38.16 | -23.27 | -1.25 | -61.02 | 48.4 | 53.01 |
| CFO/OP | -177 | 177 | 129 | 95 | -113 | 4,751 | -1,615 | -1,818 |
Ratios
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88.18 | 88.28 | 69.85 | 117 | 138 | 230 | 247 | 236 |
| Inventory Days | 19.28 | 32.08 | 35.78 | 277 | 91.25 | — | — | — |
| Days Payable | 140 | 66.91 | 32.31 | 215 | 165 | — | — | — |
| Cash Conversion Cycle | -32.49 | 53.45 | 73.32 | 178 | 63.64 | 230 | 247 | 236 |
| Working Capital Days | -147 | -115 | -811 | -5,272 | -2,553 | -3,257 | -5,998 | -9,555 |
| ROCE % | — | -120.44% | -15.31% | -13.94% | -27.01% | 0.32% | -4.68% | -13.34% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Healthfore Technologies insights
60 extracted metrics + investor summaries across FY10–FY26.
Documents
Frequently Asked Questions about Healthfore Technologies
What does Healthfore Technologies Ltd do?
Where is Healthfore Technologies Ltd (533525) listed?
Which sector does Healthfore Technologies Ltd belong to?
Company Information
HealthFore Technologies Ltd is engaged in the IT services, knowledge services and healthcare services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/533525.md for Healthfore Technologies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.